Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit


Drug Found to Clear Genital Psoriasis in Most Patients

Side effects, such as upper respiratory tract infections, injection site reactions, headache, sore throat, and itchiness, were experienced by 56% of the patients who received ixekizumab and 45% of those who received a placebo injection. Most side effects were mild to moderate.

The research was presented in October at the 18th Annual Scientific Meeting of the Sexual Medicine Society of North America (SMSNA) in San Antonio, Texas. The SMSNA is also associated with



“Ixekizumab Injection”

(Last revised: April 15, 2017)


Helwick, Caroline

“Ixekizumab Effective for Genital Psoriasis, Improves Sexual Health”

(October 31, 2017)


“Psoriasis and Sexuality”

(May 31, 2016)

Sexual Medicine Society of North America

Ryan, C, et al.

“Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis”

(Abstract presented at 18th Annual Fall Scientific Meeting of SMSNA, October 27, 2017)

« Previous 1 2 3 (page 3 of 3)